These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4148588)

  • 61. [General market for drugs: still many problems].
    Tijdschr Ziekenverpl; 1969 Jan; 22(2):83-4. PubMed ID: 5191159
    [No Abstract]   [Full Text] [Related]  

  • 62. WTO TRIPS and its effect on the supply and development of medicines in China.
    Tanner JA
    Hong Kong Med J; 2006 Feb; 12(1):84-6. PubMed ID: 16495599
    [No Abstract]   [Full Text] [Related]  

  • 63. Evaluation of similar biotherapeutic products: scientific and regulatory challenges.
    Griffiths E; Thorpe R; Wadhwa M; Sohn Y
    Biologicals; 2011 Sep; 39(5):249. PubMed ID: 21925898
    [No Abstract]   [Full Text] [Related]  

  • 64. [Reciprocal recognition of pharmaceutical committee inspection in EFTA countries].
    Sloot HA
    Pharm Weekbl; 1971 Jun; 106(23):M277+. PubMed ID: 5577664
    [No Abstract]   [Full Text] [Related]  

  • 65. [INTRODUCTION AND CONTROL OF DRUGS IN CAPITALIST COUNTRIES].
    PLANICKA K
    Cesk Farm; 1964 Sep; 13():377-9. PubMed ID: 14193011
    [No Abstract]   [Full Text] [Related]  

  • 66. Drug regulation in Canada. Proceedings of the Symposium on Medico-legal Questions in the Pharmaceutical Industry, April 20, 1977, Ontario.
    Leg Med Q; 1977 Dec; 1(4):242-62. PubMed ID: 10318528
    [No Abstract]   [Full Text] [Related]  

  • 67. Hospital workers in dispute--harmonizing Europe.
    Lister J
    N Engl J Med; 1973 Jun; 288(26):1397-9. PubMed ID: 4145280
    [No Abstract]   [Full Text] [Related]  

  • 68. U. S. pharmacy and European drug legislation.
    Rosner MM
    J Am Pharm Assoc; 1972 Dec; 12(12):627-30 passim. PubMed ID: 4637304
    [No Abstract]   [Full Text] [Related]  

  • 69. Manufacturer response to AMCP Format dossier requests.
    Lyles A; Watkins JD
    J Manag Care Pharm; 2007 Apr; 13(3):290-1; author reply 291-2. PubMed ID: 17407398
    [No Abstract]   [Full Text] [Related]  

  • 70. Students in action.
    Stead B
    Nurs Times; 1979 Dec; 75(49):2103. PubMed ID: 42041
    [No Abstract]   [Full Text] [Related]  

  • 71. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 72. This pill washes whiter.
    Fricker J
    New Sci; 1998 Oct. 31; 160(2158):22-33. PubMed ID: 11657751
    [No Abstract]   [Full Text] [Related]  

  • 73. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

  • 74. International Conference on Harmonisation; final recommendations on the revision of the permitted daily exposures for two solvents, n-methylpyrrolidone and tetrahydrofuran, according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Nov; 68(219):64352-3. PubMed ID: 14619948
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IP litigation in China could drive innovation.
    Jia H
    Nat Biotechnol; 2004 Apr; 22(4):368. PubMed ID: 15060539
    [No Abstract]   [Full Text] [Related]  

  • 76. Clinical pharmacology. The Committee on Safety of Medicines and the prescribing doctor.
    Crooks J
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):385-6. PubMed ID: 6780037
    [No Abstract]   [Full Text] [Related]  

  • 77. [International drug monitoring].
    Nir I
    Harefuah; 1973 Jan; 84(1):41-2. PubMed ID: 4692808
    [No Abstract]   [Full Text] [Related]  

  • 78. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Financial concerns prompt sponsoring pharmaceutical company to halt international phase I studies.
    Stoter G; Arnold AA; Kurzrock R; Rustin GJ
    J Natl Cancer Inst; 1994 Sep; 86(17):1353. PubMed ID: 8064897
    [No Abstract]   [Full Text] [Related]  

  • 80. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.